GRI · Forms 3, 4, 5
Insider trades at GRI Bio, Inc.
No open-market insider buys or sells at GRI Bio, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for GRI Bio, Inc. (GRI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for GRI Bio, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Leanne Kelly | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| David Leslie Szekeres | Director | Options or other derivatives | Form 4 | ||||
| David Charles Baker | Director | Options or other derivatives | Form 4 | ||||
| Camilla V Simpson | Director | Options or other derivatives | Form 4 | ||||
| Vipin Chaturvedi | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Roelof Rongen | Director | Options or other derivatives | Form 4 | ||||
| Walter Marc Hertz | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Walter Marc Hertz | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| David Leslie Szekeres | Director | Options or other derivatives | Form 4 | ||||
| David Charles Baker | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.